Despite High Awareness of Lp(a) as a Cardiovascular Risk Factor, Testing Rates Remain Alarmingly Low
Despite High Awareness of Lp(a): Lipoprotein(a), commonly abbreviated as Lp(a), has steadily gained recognition over the past decade as a powerful and independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Yet, despite growing scientific evidence and widespread clinician awareness, real-world testing rates for Lp(a) remain strikingly low—particularly in the United States. A new clinician survey…